We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Innovative Medical Device Development Center Opens in NY

By HospiMedica International staff writers
Posted on 11 May 2016
Three-dimensional (3D) printer manufacturer Stratasys (Rehovot, Israel) and the Jacobs Institute (JI; Buffalo, NY, USA) have created a research and development (R&D) center aimed at using 3D printing to test and develop new medical devices.

The new Center of Excellence (COE) will leverage Stratasys’ 3D printing technology to develop and test new medical devices using printed prototypes and models. More...
The COE will also serve as a referral center for hospitals and medical research organizations that are considering implementing 3D printing labs, and will enrich clinical education and training activities for a variety of audiences. It is also expected to aid hospitals and medical research groups in their own implementation of in-house 3D printing labs, an increasingly common phenomenon.

Stratasys supports the COE by providing advanced 3D printing solutions that feature a combination of vibrant colors and diverse material properties, including different levels of opacity and rigidity. Other partners in the COE will include Kaleida Health (Buffalo, NY, USA), the largest healthcare provider in Western New York, and the State University of New York at Buffalo (USA). Kaleida Health will participate via its vascular institute, while the University at Buffalo will share its Clinical and Translational Research Center (CTRC).

“By partnering with Stratasys, the Jacobs Institute is bringing the leader in 3D printing to Buffalo to work closely with the JI and its partners, Kaleida Health and the University at Buffalo, to accelerate the development of new medical technologies,” said Bill Maggio, CEO of the Jacobs Institute. “Working together, the respective institutions will leverage their strengths to make an impact far greater than they could make individually.”

“This announcement with the Jacobs Institute is an important milestone, marking the first time we are formally partnering with a medical organization to explore the exciting opportunities of 3D printing and healthcare,” said Scott Rader, general manager of medical solutions at Stratasys. “Stratasys brings decades of experience to the Jacobs Institute, a leader in 3D printed models, to push the boundaries of how these models can be used to train the next generation of physicians, and test new devices.”

Related Links:
Stratasys
Jacobs Institute

Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
X-Ray System
Leonardo DR mini III
Digital X-Ray Detector Panel
Acuity G4
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.